113 related articles for article (PubMed ID: 3814344)
21. Contents of monoamines in forebrain regions of alcohol-preferring (P) and -nonpreferring (NP) lines of rats.
Murphy JM; McBride WJ; Lumeng L; Li TK
Pharmacol Biochem Behav; 1987 Feb; 26(2):389-92. PubMed ID: 2437596
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion.
Musso DL; Mehta NB; Soroko FE; Ferris RM; Hollingsworth EB; Kenney BT
Chirality; 1993; 5(7):495-500. PubMed ID: 8240925
[TBL] [Abstract][Full Text] [Related]
23. Genetic influences on acquisition of tolerance to alcohol.
Erwin VG
Soc Biol; 1985; 32(3-4):222-8. PubMed ID: 3837351
[No Abstract] [Full Text] [Related]
24. Genotypic variation in the dopaminergic inhibitory control of striatal and hippocampal cholinergic activity in mice.
Durkin TP; Hashem-Zadeh H; Mandel P; Kempf J; Ebel A
Pharmacol Biochem Behav; 1983 Jul; 19(1):63-70. PubMed ID: 6684780
[No Abstract] [Full Text] [Related]
25. [The effect of medikhronal on the biogenic amine level in the brain structures and blood of animals with alcohol dependence].
Kharchenko NK
Fiziol Zh (1994); 1999; 45(4):111-9. PubMed ID: 10474811
[TBL] [Abstract][Full Text] [Related]
26. [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].
Sontag KH; Wand P; Schwarz M; Wesemann W; Osborne NN
Arzneimittelforschung; 1982; 32(10):1236-40. PubMed ID: 6891222
[TBL] [Abstract][Full Text] [Related]
27. Effects of phenethylamine derivatives on the release of biogenic amines from synaptosomes.
Raiteri M; Bertollini A; del Carmine R; Levi G
Biochem Soc Trans; 1976; 4(1):121-4. PubMed ID: 1001613
[No Abstract] [Full Text] [Related]
28. Interaction of biogenic amines with ethanol.
Smith AA
Adv Exp Med Biol; 1975; 56():265-75. PubMed ID: 238368
[TBL] [Abstract][Full Text] [Related]
29. Interaction of bradykinin with dopaminergic receptors in the CNS.
Moniuszko-Jakoniuk J; Wiśniewski K
Pol J Pharmacol Pharm; 1977; 29(3):301-11. PubMed ID: 887505
[TBL] [Abstract][Full Text] [Related]
30. Interaction of CDP-choline with synaptosomal transport of biogenic amines and their precursors in vitro and in vivo in the rat corpus striatum.
Martinet M; Fonlupt P; Pacheco H
Experientia; 1978 Sep; 34(9):1197-9. PubMed ID: 31297
[TBL] [Abstract][Full Text] [Related]
31. The effect of quipazine and LSD on monoamines in the rat striatum.
Miśkiewicz M; Rokosz-Pelc A; Vetulani J
Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
[TBL] [Abstract][Full Text] [Related]
32. Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease.
Paul R; Choudhury A; Chandra Boruah D; Devi R; Bhattacharya P; Choudhury MD; Borah A
Neurochem Int; 2017 Sep; 108():15-26. PubMed ID: 28167224
[TBL] [Abstract][Full Text] [Related]
33. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.
Kita T; Paku S; Takahashi M; Kubo K; Wagner GC; Nakashima T
Neuropharmacology; 1998 Sep; 37(9):1177-84. PubMed ID: 9833648
[TBL] [Abstract][Full Text] [Related]
34. The metabolism of biogenic amines in experimental animals and in human subjects during acute and chronic administration of ethanol.
Majchrowicz E; Hunt WA; Lahti RA; Ogata M; Karoum F
Adv Exp Med Biol; 1977; 85A():539-46. PubMed ID: 200120
[TBL] [Abstract][Full Text] [Related]
35. Dopamine levels in the striatum and the effect of alcohol and reserpine.
Wajda I; Manigault I; Hudick JP
Biochem Pharmacol; 1977 Apr; 26(7):653-5. PubMed ID: 558759
[No Abstract] [Full Text] [Related]
36. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
[TBL] [Abstract][Full Text] [Related]
37. Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics.
Yoder KK; Albrecht DS; Dzemidzic M; Normandin MD; Federici LM; Graves T; Herring CM; Hile KL; Walters JW; Liang T; Plawecki MH; O'Connor S; Kareken DA
Drug Alcohol Depend; 2016 Mar; 160():163-9. PubMed ID: 26832934
[TBL] [Abstract][Full Text] [Related]
38. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.
Stone DM; Hanson GR; Gibb JW
Neuropharmacology; 1987 Nov; 26(11):1657-61. PubMed ID: 2448703
[TBL] [Abstract][Full Text] [Related]
39. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
40. Release of biogenic amines from isolated nerve endings.
Raiteri M; Bertollini A; del Carmine R; Levi G
Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
